Cronos Group, a medical marijuana company based in Toronto, just became the first Canadian cannabis stock to trade on&a;nbsp;a U.S. exchange. The stock is trading under ticker symbol CRON on the NASDAQ, and started trading&a;nbsp;yesterday at $8.24 before closing the day at $7.62. The stock closed up 20% today at $9.17.
Cronos was previously trading as an American Depository Receipt (ADR) on the OTC markets with the ticker symbol PRMCF. It is&a;nbsp;part of &l;a href=&q;https://www.benzinga.com/trading-ideas/long-ideas/17/12/10955919/the-first-us-listed-marijuana-etf-ignites-today&q; target=&q;_blank&q; rel=&q;noopener noreferrer&q; target=&q;_blank&q;&g;the first marijuana ETF to trade on a U.S. exchange&l;/a&g;, the&a;nbsp;ETFMG Alternative Harvest ETF (ticker: MJX), &l;a href=&q;http://www.etfmj.com&q; target=&q;_blank&q; rel=&q;noopener noreferrer&q; target=&q;_blank&q;&g;where it is&a;nbsp;the top holding&l;/a&g;, comprising 9.18% of the fund.
Top 10 Medical Stocks For 2019: NBT Bancorp Inc.(NBTB)
Advisors' Opinion:- [By Stephan Byrd]
Get a free copy of the Zacks research report on NBT Bancorp (NBTB)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Max Byerly]
Get a free copy of the Zacks research report on NBT Bancorp (NBTB)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Ethan Ryder]
NBT Bancorp (NASDAQ:NBTB) was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating in a note issued to investors on Saturday.
Top 10 Medical Stocks For 2019: Equinix Inc.(EQIX)
Advisors' Opinion:- [By Matthew Frankel]
Equinix (NASDAQ:EQIX) is the largest operator of data centers in the world, with more than 9,800 companies utilizing its properties. The company provides the facility, power, security, and cooling equipment for its customers, and they supply their own servers and networking equipment.
- [By Stephan Byrd]
Traders sold shares of Equinix Inc (NASDAQ:EQIX) on strength during trading on Tuesday. $159.72 million flowed into the stock on the tick-up and $194.68 million flowed out of the stock on the tick-down, for a money net flow of $34.96 million out of the stock. Of all stocks tracked, Equinix had the 23rd highest net out-flow for the day. Equinix traded up $10.43 for the day and closed at $429.00
- [By Beth McKenna]
Equinix (NASDAQ:EQIX) reported robust first-quarter 2018 financial results after the market close on Wednesday.�
Shares closed down 6.1% on Thursday, which we can probably attribute to the company revising slightly downward its full-year 2018 adjusted funds from operations (AFFO) outlook, as we'll get to in a moment. (AFFO is a�closely watched metric for companies organized as real estate investment trusts, or REITs. It's akin to "earnings" for REITs.)�
- [By Lee Jackson]
This is one of the larger capitalization companies in the data center industry. Equinix Inc. (NASDAQ: EQIX)�provides data center services to protect and connect the information assets for the enterprises, financial services companies, and content and network providers primarily in the Americas, Europe, the Middle East, Africa and the Asia-Pacific.
- [By Craig Jones]
Kevin Kelly spoke on Bloomberg Markets about a bullish options trade in Equinix Inc (NASDAQ: EQIX).
He wants to buy the September 400/450 call spread in the name for $15.50. The trade breaks even at $415.50 or 5.41 percent above the current market price. It can maximally make a profit of $34.50. The payoff ratio is roughly 2.5 to 1, explained Kelly. He sees this as a derivative play on Microsoft Corporation's (NASDAQ: MSFT) cloud computing.
- [By Shane Hupp]
Here are some of the media stories that may have impacted Accern Sentiment Analysis’s rankings:
Get Equinix alerts: Equinix Inc (EQIX) Insider Charles J. Meyers Sells 400 Shares (americanbankingnews.com) Equinix Selects AT&T as 2018 Americas Partner of the Year (finance.yahoo.com) Equinix Inc (EQIX) Expected to Post Quarterly Sales of $1.26 Billion (americanbankingnews.com) Zacks: Analysts Anticipate Equinix Inc (EQIX) Will Announce Earnings of $5.10 Per Share (americanbankingnews.com) NetActuate Deployment to Equinix SP3 IBX庐 Data Center in Brazil Brings Faster Connections and New Services in … (benzinga.com)Several research analysts have commented on the stock. BidaskClub downgraded shares of Equinix from a “hold” rating to a “sell” rating in a research report on Friday, June 8th. Credit Suisse Group set a $525.00 price objective on shares of Equinix and gave the company a “buy” rating in a research report on Thursday, May 31st. Deutsche Bank lowered their price objective on shares of Equinix from $550.00 to $540.00 and set a “buy” rating for the company in a research report on Thursday, May 31st. ValuEngine downgraded shares of Equinix from a “hold” rating to a “sell” rating in a research report on Thursday, May 3rd. Finally, Zacks Investment Research upgraded shares of Equinix from a “sell” rating to a “hold” rating in a research report on Tuesday, May 8th. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and eighteen have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $504.29.
Top 10 Medical Stocks For 2019: CDK Global, Inc.(CDK)
Advisors' Opinion:- [By Stephan Byrd]
These are some of the headlines that may have effected Accern Sentiment’s analysis:
Get CDK Global alerts: CDK announces Connected Workshop concept (am-online.com) CDK Global announces new Connected Workshop concept (cardealermagazine.co.uk) Judge: Car dealer software companies can’t delete antitrust claims over monopolization of car dealer data (cookcountyrecord.com) CDK Global (CDK) vs. Ritchie Bros. Auctioneers (RBA) Head-To-Head Survey (americanbankingnews.com) $578.44 Million in Sales Expected for CDK Global (CDK) This Quarter (americanbankingnews.com)CDK has been the subject of a number of research analyst reports. Barrington Research restated a “hold” rating on shares of CDK Global in a research note on Monday, March 26th. BidaskClub lowered shares of CDK Global from a “sell” rating to a “strong sell” rating in a research note on Wednesday, February 21st. Zacks Investment Research lowered shares of CDK Global from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, April 3rd. Morgan Stanley lifted their price target on shares of CDK Global from $76.00 to $77.00 and gave the stock an “equal weight” rating in a research note on Wednesday, January 31st. Finally, Wells Fargo restated an “outperform” rating and issued a $80.00 price target (up previously from $75.00) on shares of CDK Global in a research note on Wednesday, January 31st. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $74.80.
- [By Shane Hupp]
Rikoon Group LLC lifted its stake in shares of CDK Global Inc (NASDAQ:CDK) by 23.1% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,873 shares of the software maker’s stock after purchasing an additional 1,102 shares during the quarter. Rikoon Group LLC’s holdings in CDK Global were worth $366,000 at the end of the most recent reporting period.
- [By Joseph Griffin]
KBC Group NV trimmed its holdings in CDK Global (NASDAQ:CDK) by 31.9% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 187,273 shares of the software maker’s stock after selling 87,562 shares during the quarter. KBC Group NV’s holdings in CDK Global were worth $11,862,000 as of its most recent filing with the Securities and Exchange Commission.
- [By Ethan Ryder]
CDK Global Inc (NASDAQ:CDK) announced a quarterly dividend on Thursday, June 7th, NASDAQ reports. Shareholders of record on Tuesday, June 19th will be given a dividend of 0.15 per share by the software maker on Friday, June 29th. This represents a $0.60 annualized dividend and a yield of 0.91%. The ex-dividend date of this dividend is Monday, June 18th.
- [By Shane Hupp]
Birch Hill Investment Advisors LLC lessened its position in shares of CDK Global Inc (NASDAQ:CDK) by 0.5% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 244,208 shares of the software maker’s stock after selling 1,175 shares during the quarter. CDK Global makes up 1.3% of Birch Hill Investment Advisors LLC’s holdings, making the stock its 29th biggest position. Birch Hill Investment Advisors LLC owned about 0.19% of CDK Global worth $15,468,000 at the end of the most recent quarter.
Top 10 Medical Stocks For 2019: Edwards Lifesciences Corporation(EW)
Advisors' Opinion:- [By ]
Edwards Lifesciences (EW) : "They have the best devices. That stock is a buy."
Align Technology (ALGN) : "The stock is breaking down. Let's wait a few days then pull the trigger."
- [By Shane Hupp]
Here are some of the media headlines that may have effected Accern Sentiment’s rankings:
Get Edwards Lifesciences alerts: Edwards Lifesciences (EW) Receives New Coverage from Analysts at Raymond James (americanbankingnews.com) [$$] ValueAct/Olympus: zoom out (finance.yahoo.com) Analysts Expect Edwards Lifesciences (EW) to Post $1.12 EPS (americanbankingnews.com) Global Central Venous Catheters Market Emerging Technology by 2023: Edwards Lifesciences, Teleflex, Lepu Medical … (thebiotechnologynews.com) Global Pulmonary Artery Catheter Market Size 2018 �� Edwards Lifesciences Corporation, Argon Medical, BD and … (thecleantechnology.com)A number of research firms have weighed in on EW. JMP Securities upped their price target on Edwards Lifesciences from $135.00 to $140.00 and gave the stock a “market outperform” rating in a report on Friday, February 2nd. SunTrust Banks restated a “buy” rating and issued a $150.00 price target on shares of Edwards Lifesciences in a report on Wednesday, January 31st. Guggenheim restated a “buy” rating and issued a $162.00 price target on shares of Edwards Lifesciences in a report on Friday, February 2nd. ValuEngine upgraded Edwards Lifesciences from a “hold” rating to a “buy” rating in a report on Monday, May 7th. Finally, Barclays upped their price target on Edwards Lifesciences from $135.00 to $155.00 and gave the stock an “overweight” rating in a report on Friday, February 2nd. Five investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. Edwards Lifesciences currently has an average rating of “Buy” and an average target price of $149.06.
- [By Todd Campbell]
It had also led to Edwards Lifesciences (NYSE:EW), a medical device company, signing on to develop ZFP-based therapeutics for cardiovascular disease.
- [By Logan Wallace]
Hartford Investment Management Co. decreased its position in shares of Edwards Lifesciences Corp (NYSE:EW) by 36.2% in the second quarter, Holdings Channel reports. The fund owned 31,580 shares of the medical research company’s stock after selling 17,905 shares during the quarter. Hartford Investment Management Co.’s holdings in Edwards Lifesciences were worth $4,597,000 as of its most recent SEC filing.
Top 10 Medical Stocks For 2019: Emerson Electric Company(EMR)
Advisors' Opinion:- [By Benzinga News Desk]
Former President George H.W. Bush has been hospitalized in Houston with an infection, just after attending the funeral of his wife, Barbara, a spokesman said Monday: Link
ECONOMIC DATA Redbook Reports US Retail Sales During First 2 Weeks Of Apr. Up 0.3% MoM, Up 2.8% YoY USA S&P/CaseShiller House Price Index (MoM) for Feb Up 0.7% MoM New home sales report for March will be released at 10:00 a.m. ET. The Conference Board’s consumer sentiment index for April is schedule for release at 10:00 a.m. ET. The Richmond Fed manufacturing index for April will be released at 10:00 a.m. ET. The Treasury is set to auction 4-and 52-week bills at 11:30 a.m. ET. The Treasury will auction 2-year notes at 1:00 p.m. ET. ANALYST RATINGS Leerink upgraded Cardinal Health (NYSE: CAH) from Market Perform to Outperform Berenberg upgraded Emerson Electric (NYSE: EMR) from Sell to Hold Mizuho downgraded Skyworks (NASDAQ: SWKS) from Buy to Neutral BMO downgraded Texas Roadhouse (NASDAQ: TXRH) from Outperform to Market PerformThis is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.
- [By Shane Hupp]
Element Capital Management LLC acquired a new stake in Emerson Electric Co. (NYSE:EMR) in the 1st quarter, HoldingsChannel.com reports. The fund acquired 202,986 shares of the industrial products company’s stock, valued at approximately $13,864,000.
- [By Max Byerly]
Flippin Bruce & Porter Inc. decreased its holdings in Emerson Electric (NYSE:EMR) by 33.6% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 66,251 shares of the industrial products company’s stock after selling 33,574 shares during the quarter. Flippin Bruce & Porter Inc.’s holdings in Emerson Electric were worth $4,525,000 as of its most recent filing with the Securities & Exchange Commission.
- [By Lee Samaha]
In common with many other industrial companies, like Danaher, Pentair has been taking action to become a more focused investment proposition for investors. The sale of its valves and controls business to Emerson Electric (NYSE:EMR) in the spring of 2017 turned out to be well-timed for Emerson, as it occurred precisely at the time when oil and gas capital spending started picking up.
- [By Ethan Ryder]
Cullen Frost Bankers Inc. reduced its stake in Emerson Electric Co. (NYSE:EMR) by 4.2% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 80,915 shares of the industrial products company’s stock after selling 3,534 shares during the quarter. Cullen Frost Bankers Inc.’s holdings in Emerson Electric were worth $5,527,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
- [By Stephan Byrd]
Hartford Investment Management Co. lessened its stake in Emerson Electric Co. (NYSE:EMR) by 36.3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 83,231 shares of the industrial products company’s stock after selling 47,372 shares during the period. Hartford Investment Management Co.’s holdings in Emerson Electric were worth $5,755,000 at the end of the most recent quarter.
Top 10 Medical Stocks For 2019: OneMain Holdings, Inc.(OMF)
Advisors' Opinion:- [By Max Byerly]
Rhumbline Advisers boosted its position in shares of OneMain Holdings Inc (NYSE:OMF) by 18.8% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 59,772 shares of the financial services provider’s stock after acquiring an additional 9,479 shares during the period. Rhumbline Advisers’ holdings in OneMain were worth $1,790,000 as of its most recent filing with the Securities & Exchange Commission.
- [By Shane Hupp]
Get a free copy of the Zacks research report on OneMain (OMF)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Max Byerly]
OneMain (NYSE: OMF) and Provident Financial (OTCMKTS:FPLPY) are both finance companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, earnings, profitability, analyst recommendations, valuation and risk.
Top 10 Medical Stocks For 2019: Marathon Petroleum Corporation(MPC)
Advisors' Opinion:- [By Joseph Griffin]
Strategic Global Advisors LLC raised its stake in shares of Marathon Petroleum Corp (NYSE:MPC) by 38.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 16,244 shares of the oil and gas company’s stock after purchasing an additional 4,480 shares during the quarter. Strategic Global Advisors LLC’s holdings in Marathon Petroleum were worth $1,188,000 as of its most recent filing with the Securities and Exchange Commission.
- [By Lee Jackson]
Not only is Marathon Petroleum Corp. (NYSE: MPC) the newest member of the Franchise List, but it is a returning member. Also, the company has begun�of the long process of completing a massive purchase of another refining giant. Marathon agreed to buy rival Andeavor (NYSE: ANDV) for $23.3 billion in the biggest-ever deal for an oil refiner. That would create the largest independent fuel maker in the United States.
- [By Maxx Chatsko]
The combination of pipeline bottlenecks is now dragging down the price of West Texas Intermediate (WTI) crude oil to levels well below that of Brent crude. The difference between the two is called the Brent-WTI spread -- and it's now at levels last witnessed in 2015, and never before 2011. This single metric also explains why oil refinery stocks such as Marathon Petroleum (NYSE:MPC), Phillips 66 (NYSE:PSX), and Delek US Holdings (NYSE:DK) are up by as much as 51% this year.
- [By Lisa Levin] Gainers Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) rose 34.7 percent to $45.50 in pre-market trading following news that the FDA has approved Andexxa for the reversal of factor Xa inhibitors. Euro Tech Holdings Company Limited (NASDAQ: CLWT) rose 15.7 percent to $6.65 in pre-market trading after climbing 155.56 percent on Thursday. China Recycling Energy Corporation (NASDAQ: CREG) rose 14.7 percent to $2.75 in pre-market trading after climbing 57.89 percent on Thursday. Pandora Media, Inc. (NYSE: P) rose 11 percent to $6.40 in pre-market trading after reporting strong quarterly results. Fred's, Inc. (NASDAQ: FRED) rose 9.2 percent to $1.90 in pre-market trading following Q4 results. Shake Shack Inc (NYSE: SHAK) rose 9.1 percent to $51.70 in pre-market trading after the company reported upbeat results for its first quarter and raised its FY18 guidance. Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) rose 9 percent to $12.55 in pre-market trading after the company posted Q1 results and agreed to acquire HealthGrid. Weight Watchers International, Inc. (NYSE: WTW) rose 7.6 percent to $75 in pre-market trading after the company reported stronger-than-expected results for its first quarter. The company also raised its FY18 earnings outlook from $2.40-$2.70 to $3-$3.20. Viavi Solutions Inc. (NASDAQ: VIAV) rose 7.5 percent to $10.15 in pre-market trading following Q3 results. Pearson plc (NYSE: PSO) rose 4.5 percent to $11.83 in pre-market trading after reporting strong quarterly earnings. Alibaba Group Holding Ltd (NYSE: BABA) shares rose 4.4 percent to $190.50 in the pre-market trading session as the company posted upbeat Q4 results. Aqua Metals, Inc. (NASDAQ: AQMS) shares rose 3.9 percent to $4.30 in pre-market trading after gaining 6.98 percent on Thursday. Newell Brands Inc (NYSE: NWL) shares rose 3.6 percent to $27.65 in pre-market trading after reporting upbeat quarterly earnings. HMS Holdings Corp (NASDAQ: H
- [By Tyler Crowe]
There has been a slew of merger & acquisition activity in the refining industry as of late as companies look to add economy of scale. The rate of consolidation went into warp speed last week when Marathon Petroleum (NYSE:MPC) and Andeavor (NYSE:ANDV) announced their $23 billion merger deal. HollyFrontier isn't a big fish in this industry, but it does have a reputation for making value-adding acquisitions. So of course, an analyst asked CEO George Damiris on the company's conference call for his view of the M&A market and what we might expect from HollyFrontier. Here's his response:�
- [By Matthew DiLallo]
MPLX (NYSE:MPLX) has undergone a significant transformation over the past year and a half. The master limited partnership (MLP) completed several transactions with its oil refining parent Marathon Petroleum (NYSE:MPC), which diversified its midstream portfolio and eliminated costly management fees. Those moves position MPLX to continue growing its rock-solid 6.8%-yielding payout at a healthy clip for the next several years, making it an excellent option for income-seeking investors to consider buying.
Top 10 Medical Stocks For 2019: Resolute Energy Corporation(REN )
Advisors' Opinion:- [By Max Byerly]
Republic Protocol (CURRENCY:REN) traded 15% lower against the U.S. dollar during the one day period ending at 16:00 PM E.T. on June 23rd. Over the last week, Republic Protocol has traded down 25.4% against the U.S. dollar. One Republic Protocol token can now be purchased for approximately $0.0590 or 0.00000961 BTC on popular cryptocurrency exchanges including OKEx, IDEX, DDEX and Cobinhood. Republic Protocol has a market capitalization of $32.57 million and $2.71 million worth of Republic Protocol was traded on exchanges in the last 24 hours.
- [By Shane Hupp]
Republic Protocol (CURRENCY:REN) traded 8.6% lower against the dollar during the 1-day period ending at 12:00 PM E.T. on June 13th. Republic Protocol has a total market capitalization of $39.37 million and $1.56 million worth of Republic Protocol was traded on exchanges in the last 24 hours. Over the last week, Republic Protocol has traded 22.7% lower against the dollar. One Republic Protocol token can now be purchased for $0.0757 or 0.00001210 BTC on popular exchanges including Cobinhood, IDEX, DDEX and Liqui.
Top 10 Medical Stocks For 2019: Banco Bradesco Sa(BBDO)
Advisors' Opinion:- [By Ethan Ryder]
News articles about Banco Bradesco (NYSE:BBDO) have trended somewhat positive this week, Accern Sentiment Analysis reports. Accern identifies positive and negative press coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Banco Bradesco earned a news impact score of 0.19 on Accern’s scale. Accern also gave news stories about the bank an impact score of 46.8086143489448 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
Top 10 Medical Stocks For 2019: Host Hotels & Resorts, Inc.(HST)
Advisors' Opinion:- [By Logan Wallace]
Host Hotels & Resorts (NYSE:HST) had its price objective boosted by Stifel Nicolaus from $20.50 to $21.00 in a research note published on Thursday. They currently have a buy rating on the real estate investment trust’s stock.
- [By Max Byerly]
ING Groep NV increased its stake in shares of Host Hotels & Resorts (NYSE:HST) by 6.6% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 75,007 shares of the real estate investment trust’s stock after buying an additional 4,642 shares during the quarter. ING Groep NV’s holdings in Host Hotels & Resorts were worth $1,398,000 at the end of the most recent reporting period.
- [By Logan Wallace]
Avalon Advisors LLC cut its stake in Host Hotels and Resorts Inc (NYSE:HST) by 0.4% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 793,510 shares of the real estate investment trust’s stock after selling 3,414 shares during the period. Avalon Advisors LLC owned about 0.11% of Host Hotels and Resorts worth $14,791,000 at the end of the most recent reporting period.
No comments:
Post a Comment